Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that mainly affects both upper and lower motor neurons, accompanied by motor symptoms (Taylor et al., 2016). Cytoplasmic accumulation of TDP-43 in motor neurons is the most prominent pathological feature in ALS, which results in impaired protein quality control, mitochondrial dysfunction, and altered stress granule dynamics (Shahheydari et al., 2017; Davis et al., 2018; McDonald et al., 2011). This cytoplasmic accumulation often accompanies depletion of TDP-43 in the nucleus (Neumann et al., 2006), which then results in the loss of its nuclear functions including mRNA splicing (Highley et al., 2014) and the regulation of transcription (Amlie-Wolf et al., 2015). In addition to its occurrence in ALS, the cytoplasmic accumulation of TDP-43 in neurons is also observed in frontotemporal dementia (FTD; about 50% of patients) (Neumann et al., 2006), as well as in Alzheimer’s (Amador-Ortiz et al., 2007), Parkinson’s (Nakashima-Yasuda et al., 2007), and Huntington’s diseases (Schwab et al., 2008), although with lower frequency compared to ALS. These data suggest the importance of proper nucleocytoplasmic localization of TDP-43 for neuronal function.

TDP-43 is known to localize mainly in the nucleus of most neurons examined in non-pathological conditions (Diaper et al., 2013; Neumann et al., 2006; Uchino et al., 2015). Post-translational modifications (PTMs), such as ubiquitination and phosphorylation, and fragmentation of TDP-43 were shown to affect interactions among TDP-43 protein themselves and between TDP-43 and Importins, thereby promoting cytoplasmic accumulation of TDP-43 under pathological conditions including ALS (Neumann et al., 2006; Nonaka et al., 2009). Consistent with these findings, recently, a feedback cycle between nucleocytoplasmic transport (NCT) defect and TDP-43 aggregation was proposed as a model to explain cytoplasmic accumulation of TDP-43 in ALS conditions (Solomon et al., 2018; Gasset-Rosa et al., 2019). In this model, aggregation of TDP-43 in the cytoplasm captures the components (e.g., Importins) of NCT, causing NCT defects and reduced translocation of TDP-43 to the nucleus. These defects increase the amount of TDP-43 in the cytoplasm, which further accelerates cytoplasmic aggregation of TDP-43. Although this model explains the late stages of the disease very well, it remains unclear how this feedback cycle is initiated at the early stages or what predisposes neurons to be vulnerable to this feedback cycle.

Of note, TDP-43 has a property of shuttling between the nucleus and the cytoplasm in neurons under non-pathological conditions, and several factors have been shown to contribute to its NCT. Numerous studies have demonstrated contributions of nuclear transport machineries to NCT of TDP-43, including Importins (Importin α2, α3, and β1) (Nishimura et al., 2010; Solomon et al., 2018), RanGAP (Chou et al., 2018), and components of nuclear pore complexes (Nup62 and Nup54) (Nishimura et al., 2010). The signal sequences for NCT of TDP-43 have been reported: the nuclear localization signal (NLS) of TDP-43 was first identified in both cultured neurons and mouse brains, and its deletion resulted in cytoplasmic accumulation of TDP-43 (Winton et al., 2008). In contrast, deletion of a computationally predicted, leucine-rich nuclear export signal (NES) located at amino acids 239–250 in human TDP-43 (Winton et al., 2008) showed no significant effects on translocation of TDP-43 towards the cytoplasm in neurons (Pinarbasi et al., 2018).

Given that TDP-43 has distinct cytoplasmic functions in addition to its nuclear functions, TDP-43 localization can be dynamically changed (i.e. from nucleus to cytoplasm and vice versa) upon specific cellular demands for its location-specific functions. Although some specific pathological conditions, such as increased stress granule formation (Colombrita et al., 2009) or decreased autophagy (Nguyen et al., 2019), are known to induce cytoplasmic accumulation of TDP-43, it remains elusive whether there exist in neurons certain non-pathological cellular events in which the localization of TDP-43 shifts significantly from the nucleus to cytoplasm and vice versa. In this study, we found that TDP-43 shows cell-type-dependent variation in its localization and can undergo dynamic and reversible changes in its localization during development, one of the major cellular events, in Drosophila sensory neurons. Furthermore, we identify cytosolic calcium as a key cellular factor that controls nucleocytoplasmic localization of TDP-43 and establish the cytosolic calcium-Calpain-A-Importin α3 pathway as a molecular mechanism underlying NCT-mediated cytoplasmic accumulation of TDP-43 in Drosophila neurons.

In this study, we demonstrate a role of the calcium-CalpA-Imp α3 pathway in regulation of cytoplasmic accumulation of TDP-43. The involvement of this pathway further extends the previously proposed feedback cycle model (Solomon et al., 2018). In the previous model, amounts of cytoplasmic TDP-43 are increased through NCT defects caused by cytoplasmic aggregation of TDP-43, and increased levels of TDP-43 in the cytoplasm further accelerate TDP-43 aggregation. Our results provide an additional pathway that can increase the amounts of cytoplasmic TDP-43. How the calcium-CalpA-Imp α3 pathway interacts with the events in the feedback cycle model during progression of ALS is not certain. Interestingly, although modulation of cytosolic calcium levels led to reversible translocation of TDP-43 between the cytoplasm and the nucleus, TDP-43 aggregates were not observed in our study. Given this observation, the calcium-CalpA-Imp α3 pathway is likely to precede the sequestration of Importins by cytoplasmic TDP-43 aggregates and the subsequent NCT defects in the feedback cycle model. Therefore, our results provide an early regulatory mode to be therapeutically targeted for prevention of cytoplasmic accumulation of TDP-43 in ALS (Figure 7—figure supplement 1). In addition, we showed calcium-dependent dynamic changes of TDP-43 localization in neurons in response to the changes in cellular context during development. Together with a recent study showing shift in TDP-43 localization from nucleus to cytoplasm in skeletal muscle cells during regeneration (Vogler et al., 2018), our results suggest that translocation of TDP-43 is not necessarily pathological. This conclusion is supported by a recent study in which nuclear depletion and cytoplasmic accumulation of TDP-43 were observed in a subpopulation of neurons from various areas of healthy mouse brain (Termsarasab et al., 2020). These findings raise a new possibility that dynamic control of TDP-43 translocation can contribute to cytoplasmic accumulation of TDP-43 in ALS (Figure 7—figure supplement 2).

Among the candidate molecules selected from the genetic screen (Figure 4 and Figure 4—figure supplement 1), we focused on CalpA and Imp α3 during the search of the mechanism. However, in addition to CalpA and Imp α3, the candidate molecules also included two other calcium-dependent regulator candidates (Cam and Pkc53E) and four other nuclear import components (Imp α1, Imp β1, Imp 7, and Tnpo-SR). Cam acts as a nuclear transporter of sex-determining region Y (SRY), independent of Importin (Kaur et al., 2010). However, Cam was excluded from the following experiments because of no Cam-binding site in TBPH, as well as the lethality induced by its overexpression. In contrast, Pkc53E regulates nucleocytoplasmic localization of diacylglycerol kinase ζ (Topham et al., 1998) and ribosomal protein S6 kinase (S6K) by inhibiting functions of their NLSs via phosphorylation (Valovka et al., 2003). Pkc53E showed a comparable effect to CalpA on the localization of TBPH (Figure 4C). These data suggest the existence of an additional, Pkc53E-dependent pathway to regulate TBPH localization. Imp αs are known to form heterodimers with Imp βs (Moroianu et al., 1995, Jäkel et al., 1999) , suggesting that Imp α3 and Imp β1 may form a heterodimer to participate in our pathway. Indeed, disrupting this pathway via reducing CalpA level appears to interfere with nuclear translocation of another NLS-bearing protein, polyQ (MJDtr-78Q; Figure 7—figure supplement 3A), which is known to be transported via Imp α3 (Sowa et al., 2018). Notably, a reduction in CalpA mitigated polyQ-induced retinal degeneration (Figure 7—figure supplement 3B). These data suggest that calcium-mediated CalpA activity may affect nuclear localization of a broad range of proteins via Imp α3.

Calpains have been associated with neurotoxicity in a number of diseases including ALS (Vosler et al., 2008). There are 15 genes encoding calpains in mammals (Evans and Turner, 2007), among which Calpain-1 and −2 are most studied. In Neuro2a cells and in motor cortex of patients with frontotemporal lobar degeneration with clinical features of motor neuron disease (FTLD-MND), Yamashita et al., 2012 showed that Calpain-1 and −2 are responsible for the calcium-mediated cleavage of TDP-43, leading to its toxic accumulation in the cytoplasm. Calpain-mediated cleavage of TDP-43 into CTF-25 and CTF-35 during traumatic brain injury in mice has also been reported (Yang et al., 2014). In Drosophila, CalpA is most similar to Calpain-9 (Thurmond et al., 2019). Therefore, some of the functions of Calpain-1 and −2, such as cleavage of TDP-43, may not be conserved in CalpA. To test whether CalpA used in this study can also cleave TBPH, we overexpressed CalpA in fly heads and measured the amount and size of TBPH via western blot and compared them to the control. We found that CalpA overexpression led to no apparent pattern of TBPH cleavage on the blot (Figure 7—figure supplement 4A and B), although unexpectedly, it led to an increase in the amount of TBPH. Instead, we showed that CalpA is necessary for nuclear import of TBPH (Figure 4B and C) through a yet undefined mechanism. These data suggest that CalpA, unlike Calpain-1 and −2, does not cleave TBPH and instead may be protective against TBPH-mediated toxicity.

Knockdown of CalpA blocked nuclear translocation of Imp α3 in pupal C4da neurons (Figure 5A and B), suggesting that CalpA functions as an upstream regulator of Imp α3. A specific mechanism by which CalpA regulates TBPH translocation through Imp α3 remains to be shown. Calpain, a human orthologue of CalpA, is a protease with a broad spectrum of substrates (DuVerle et al., 2011). However, Importin α3, a human orthologue of Imp α3, has not been reported as a substrate of Calpain, nor predicted using the Calpain cleavage detector (CCD) software (Liu et al., 2011). These data suggest the possibility that CalpA regulates nuclear translocation of Imp α3 indirectly via its another target protein associated with nuclear import or export of Imp α3. Further functional study is needed to test the validity of this hypothesis.

Based on our data, Imp α3/β1 complex is the major transport regulator for nuclear import of TBPH (Figure 4—figure supplement 2A and B). Interestingly, knockdown of Imp α1, Tnpo-SR, and Imp seven also led to a significant shift in TBPH localization from the nucleus to the cytoplasm in pupae. TDP-43 has been shown to interact with both KPNA4 and KPNA6, the orthologs for which are Imp α3 and Imp α1, respectively (Nishimura et al., 2010). Interestingly, ectopic expression of Imp α1 in Drosophila eyes rescued glassy-eye phenotype of Imp α3 mutant (Mason et al., 2003), suggesting that Imp α1 and Imp α3 have somewhat redundant functions. Thus, it is not surprising that knockdown of Imp α1 also disrupted nuclear transport of TBPH. Whether Imp α1 also receives regulation from CalpA remains to be shown. As for Imp7 and Tnpo-SR, they both function at the upstream of mRNA splicing. Imp7 binds directly to small nuclear ribonucleoproteins (snRNPs), which are indispensable constituents of a spliceosome, and localizes them into Cajal bodies (Natalizio and Matera, 2013). Now, spliceosome assembly is also mediated by serine/arginine-rich splicing factor 1 (SRSF1) (Cho et al., 2011), which is transported into the nucleus by Tnpo-SR (Allemand et al., 2002). Notably, 517 and 333 SRSF1-regulated alternative splicing events were identified in 3D MCF-10A acini and HeLa cells, respectively (Anczuków et al., 2015). We surmise that knockdown of Imp7 and Tnpo-SR may cause widespread changes in alternative splicing, the result of which may impede TBPH import into the nucleus.

We reported in this study that TBPH localization shifts from the cytoplasm (at larval period) to the nucleus (at pupal period), but for what reason TBPH translocates into the nucleus during the pupal stage remains unknown. Interestingly, a previous study (Vanden Broeck et al., 2013) showed that loss of function of TBPH leads to increased Map205 expression, resulting in cytoplasmic mis-localization of ecdysone receptor-A (EcR-A), an isoform of EcR expressed predominantly during the late stages of pupa. These results raise a possibility that in C4da neurons, TBPH translocates into the nucleus during pupal stage to regulate the expression of Map205 and thus the nuclear localization of EcR-A, an important step for proper metamorphosis. Of note, several previous studies showed that the loss of liver X receptor β (LXRβ), a mammalian ortholog of EcR, results in motor neuron degeneration (Andersson et al., 2005; Bigini et al., 2010) and that LXRβ physically interacts with TDP-43 (Vanden Broeck et al., 2013). Another previous study showed that LXRβ links β-sitosterol to ALS-parkinsonism dementia complex (Kim et al., 2008). Furthermore, single-nucleotide polymorphisms (SNPs) for LXRβ were recently identified to be associated with the age of onset in ALS patients (Mouzat et al., 2018). These studies strongly suggest that disrupted LXRβ (EcR) signaling pathway may be associated with motor neuron diseases such as ALS. Taken together, it seems possible that neurons dynamically control the nucleocytoplasmic translocation of TDP-43 upon specific cellular demands such as regulation of LXRβ signaling associated with ALS pathogenesis.

Previous studies reported that increased calcium was observed in motor neurons of ALS mouse models (von Lewinski and Keller, 2005). Together with the fact that excessive intracellular calcium over the manageable capacity is able to trigger cell death, these observations support the idea that decreasing calcium can be an effective strategy to treat ALS. Consistent with this idea, riluzole, the FDA-approved medication for ALS, appears to delay the disease progression for 3 months by inhibiting calcium-mediated excitotoxicity. However, in a recent post-hoc study, the beneficial effect of riluzole was shown to be evident at late stage of ALS (stage 4), but not at earlier stages (stages 2 and 3) (Fang et al., 2018). Consistent with this post-hoc study, a previous study suggested that early intrinsic hyperexcitability may not contribute to motor neuron degeneration in ALS (Leroy et al., 2014). Moreover, a potentially protective function of calcium in motor neurons of ALS models at their early developmental stages has been reported (Saxena et al., 2013; Armstrong and Drapeau, 2013). Taken together, these findings suggest a possibility that intracellular calcium may have a concentration-dependent shift in its net effect on ALS pathogenesis from being protective to pathogenic as disease progresses. Our finding of the calcium-CalpA-Imp α3 pathway may provide a mechanistic insight to understand the role of calcium in ALS pathogenesis.

All data generated or analysed during this study are included in the manuscript and supporting files.

1. 1. Allemand E
   2. Dokudovskaya S
   3. Bordonné R
   4. Tazi J

   (2002) A conserved Drosophila transportin-serine/arginine-rich (SR) protein permits nuclear import of Drosophila SR protein splicing factors and their antagonist repressor splicing factor 1

   Molecular Biology of the Cell 13:2436–2447.

   https://doi.org/10.1091/mbc.e02-02-0102

   • PubMed
   • Google Scholar
2. 1. Amador-Ortiz C
   2. Lin WL
   3. Ahmed Z
   4. Personett D
   5. Davies P
   6. Duara R
   7. Graff-Radford NR
   8. Hutton ML
   9. Dickson DW

   (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease

   Annals of Neurology 61:435–445.

   https://doi.org/10.1002/ana.21154

   • PubMed
   • Google Scholar
3. 1. Amlie-Wolf A
   2. Ryvkin P
   3. Tong R
   4. Dragomir I
   5. Suh E
   6. Xu Y
   7. Van Deerlin VM
   8. Gregory BD
   9. Kwong LK
   10. Trojanowski JQ
   11. Lee VM
   12. Wang LS
   13. Lee EB

   (2015) Transcriptomic changes due to cytoplasmic TDP-43 expression reveal dysregulation of histone transcripts and nuclear chromatin

   PLOS ONE 10:e0141836.

   https://doi.org/10.1371/journal.pone.0141836

   • PubMed
   • Google Scholar
4. 1. Anczuków O
   2. Akerman M
   3. Cléry A
   4. Wu J
   5. Shen C
   6. Shirole NH
   7. Raimer A
   8. Sun S
   9. Jensen MA
   10. Hua Y
   11. Allain FH
   12. Krainer AR

   (2015) SRSF1-Regulated alternative splicing in breast Cancer

   Molecular Cell 60:105–117.

   https://doi.org/10.1016/j.molcel.2015.09.005

   • PubMed
   • Google Scholar
5. 1. Andersson S
   2. Gustafsson N
   3. Warner M
   4. Gustafsson JA

   (2005) Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice

   PNAS 102:3857–3862.

   https://doi.org/10.1073/pnas.0500634102

   • PubMed
   • Google Scholar
6. 1. Armstrong GA
   2. Drapeau P

   (2013) Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS

   Journal of Neuroscience 33:1741–1752.

   https://doi.org/10.1523/JNEUROSCI.4003-12.2013

   • PubMed
   • Google Scholar
7. 1. Barmada SJ
   2. Skibinski G
   3. Korb E
   4. Rao EJ
   5. Wu JY
   6. Finkbeiner S

   (2010) Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis

   Journal of Neuroscience 30:639–649.

   https://doi.org/10.1523/JNEUROSCI.4988-09.2010

   • PubMed
   • Google Scholar
8. 1. Bigini P
   2. Steffensen KR
   3. Ferrario A
   4. Diomede L
   5. Ferrara G
   6. Barbera S
   7. Salzano S
   8. Fumagalli E
   9. Ghezzi P
   10. Mennini T
   11. Gustafsson JA

   (2010) Neuropathologic and biochemical changes during disease progression in liver X receptor beta-/- mice, a model of adult neuron disease

   Journal of Neuropathology and Experimental Neurology 69:593–605.

   https://doi.org/10.1097/NEN.0b013e3181df20e1

   • PubMed
   • Google Scholar
9. 1. Cho S
   2. Hoang A
   3. Sinha R
   4. Zhong XY
   5. Fu XD
   6. Krainer AR
   7. Ghosh G

   (2011) Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly

   PNAS 108:8233–8238.

   https://doi.org/10.1073/pnas.1017700108

   • PubMed
   • Google Scholar
10. 1. Chou CC
    2. Zhang Y
    3. Umoh ME
    4. Vaughan SW
    5. Lorenzini I
    6. Liu F
    7. Sayegh M
    8. Donlin-Asp PG
    9. Chen YH
    10. Duong DM
    11. Seyfried NT
    12. Powers MA
    13. Kukar T
    14. Hales CM
    15. Gearing M
    16. Cairns NJ
    17. Boylan KB
    18. Dickson DW
    19. Rademakers R
    20. Zhang YJ
    21. Petrucelli L
    22. Sattler R
    23. Zarnescu DC
    24. Glass JD
    25. Rossoll W

    (2018) TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD

    Nature Neuroscience 21:228–239.

    https://doi.org/10.1038/s41593-017-0047-3

    • PubMed
    • Google Scholar
11. 1. Colombrita C
    2. Zennaro E
    3. Fallini C
    4. Weber M
    5. Sommacal A
    6. Buratti E
    7. Silani V
    8. Ratti A

    (2009) TDP-43 is recruited to stress granules in conditions of oxidative insult

    Journal of Neurochemistry 111:1051–1061.

    https://doi.org/10.1111/j.1471-4159.2009.06383.x

    • PubMed
    • Google Scholar
12. 1. Daniels RW
    2. Rossano AJ
    3. Macleod GT
    4. Ganetzky B

    (2014) Expression of multiple transgenes from a single construct using viral 2A peptides in Drosophila

    PLOS ONE 9:e100637.

    https://doi.org/10.1371/journal.pone.0100637

    • PubMed
    • Google Scholar
13. 1. Davis SA
    2. Itaman S
    3. Khalid-Janney CM
    4. Sherard JA
    5. Dowell JA
    6. Cairns NJ
    7. Gitcho MA

    (2018) TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics

    Neuroscience Letters 678:8–15.

    https://doi.org/10.1016/j.neulet.2018.04.053

    • PubMed
    • Google Scholar
14. 1. DeJesus-Hernandez M
    2. Mackenzie IR
    3. Boeve BF
    4. Boxer AL
    5. Baker M
    6. Rutherford NJ
    7. Nicholson AM
    8. Finch NA
    9. Flynn H
    10. Adamson J
    11. Kouri N
    12. Wojtas A
    13. Sengdy P
    14. Hsiung GY
    15. Karydas A
    16. Seeley WW
    17. Josephs KA
    18. Coppola G
    19. Geschwind DH
    20. Wszolek ZK
    21. Feldman H
    22. Knopman DS
    23. Petersen RC
    24. Miller BL
    25. Dickson DW
    26. Boylan KB
    27. Graff-Radford NR
    28. Rademakers R

    (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

    Neuron 72:245–256.

    https://doi.org/10.1016/j.neuron.2011.09.011

    • PubMed
    • Google Scholar
15. 1. Diaper DC
    2. Adachi Y
    3. Sutcliffe B
    4. Humphrey DM
    5. Elliott CJ
    6. Stepto A
    7. Ludlow ZN
    8. Vanden Broeck L
    9. Callaerts P
    10. Dermaut B
    11. Al-Chalabi A
    12. Shaw CE
    13. Robinson IM
    14. Hirth F

    (2013) Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes

    Human Molecular Genetics 22:1539–1557.

    https://doi.org/10.1093/hmg/ddt005

    • PubMed
    • Google Scholar
16. 1. DuVerle DA
    2. Ono Y
    3. Sorimachi H
    4. Mamitsuka H

    (2011) Calpain cleavage prediction using multiple kernel learning

    PLOS ONE 6:e19035.

    https://doi.org/10.1371/journal.pone.0019035

    • PubMed
    • Google Scholar
17. 1. Evans JS
    2. Turner MD

    (2007) Emerging functions of the calpain superfamily of cysteine proteases in neuroendocrine secretory pathways

    Journal of Neurochemistry 103:849–859.

    https://doi.org/10.1111/j.1471-4159.2007.04815.x

    • PubMed
    • Google Scholar
18. 1. Fang T
    2. Al Khleifat A
    3. Meurgey JH
    4. Jones A
    5. Leigh PN
    6. Bensimon G
    7. Al-Chalabi A

    (2018) Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study

    The Lancet Neurology 17:416–422.

    https://doi.org/10.1016/S1474-4422(18)30054-1

    • PubMed
    • Google Scholar
19. 1. Gant JC
    2. Sama MM
    3. Landfield PW
    4. Thibault O

    (2006) Early and simultaneous emergence of multiple hippocampal biomarkers of aging is mediated by Ca2+-induced Ca2+ release

    Journal of Neuroscience 26:3482–3490.

    https://doi.org/10.1523/JNEUROSCI.4171-05.2006

    • PubMed
    • Google Scholar
20. 1. Gasset-Rosa F
    2. Lu S
    3. Yu H
    4. Chen C
    5. Melamed Z
    6. Guo L
    7. Shorter J
    8. Da Cruz S
    9. Cleveland DW

    (2019) Cytoplasmic TDP-43 De-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death

    Neuron 102:339–357.

    https://doi.org/10.1016/j.neuron.2019.02.038

    • PubMed
    • Google Scholar
21. 1. Han C
    2. Jan LY
    3. Jan Y-N

    (2011) Enhancer-driven membrane markers for analysis of nonautonomous mechanisms reveal neuron-glia interactions in Drosophila

    PNAS 108:9673–9678.

    https://doi.org/10.1073/pnas.1106386108

    • Google Scholar
22. 1. Hergesheimer RC
    2. Chami AA
    3. de Assis DR
    4. Vourc'h P
    5. Andres CR
    6. Corcia P
    7. Lanznaster D
    8. Blasco H

    (2019) The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?

    Brain 142:1176–1194.

    https://doi.org/10.1093/brain/awz078

    • PubMed
    • Google Scholar
23. 1. Herzog JJ
    2. Deshpande M
    3. Shapiro L
    4. Rodal AA
    5. Paradis S

    (2017) TDP-43 misexpression causes defects in dendritic growth

    Scientific Reports 7:15656.

    https://doi.org/10.1038/s41598-017-15914-4

    • PubMed
    • Google Scholar
24. 1. Herzog JJ
    2. Xu W
    3. Deshpande M
    4. Rahman R
    5. Suib H
    6. Rodal AA
    7. Rosbash M
    8. Paradis S

    (2020) TDP-43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression

    PNAS 117:11760–11769.

    https://doi.org/10.1073/pnas.1917038117

    • PubMed
    • Google Scholar
25. 1. Highley JR
    2. Kirby J
    3. Jansweijer JA
    4. Webb PS
    5. Hewamadduma CA
    6. Heath PR
    7. Higginbottom A
    8. Raman R
    9. Ferraiuolo L
    10. Cooper-Knock J
    11. McDermott CJ
    12. Wharton SB
    13. Shaw PJ
    14. Ince PG

    (2014) Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones

    Neuropathology and Applied Neurobiology 40:670–685.

    https://doi.org/10.1111/nan.12148

    • PubMed
    • Google Scholar
26. 1. Hwang RY
    2. Zhong L
    3. Xu Y
    4. Johnson T
    5. Zhang F
    6. Deisseroth K
    7. Tracey WD

    (2007) Nociceptive neurons protect Drosophila larvae from parasitoid wasps

    Current Biology 17:2105–2116.

    https://doi.org/10.1016/j.cub.2007.11.029

    • PubMed
    • Google Scholar
27. 1. Jäkel S
    2. Albig W
    3. Kutay U
    4. Bischoff FR
    5. Schwamborn K
    6. Doenecke D
    7. Görlich D

    (1999) The importin β/importin 7 heterodimer is a functional nuclear import receptor for histone H1

    The EMBO Journal 18:2411–2423.

    https://doi.org/10.1093/emboj/18.9.2411

    • Google Scholar
28. 1. Joshi R
    2. Venkatesh K
    3. Srinivas R
    4. Nair S
    5. Hasan G

    (2004) Genetic dissection of itpr gene function reveals a vital requirement in aminergic cells of Drosophila larvae

    Genetics 166:225–236.

    https://doi.org/10.1534/genetics.166.1.225

    • PubMed
    • Google Scholar
29. 1. Kanamori T
    2. Kanai MI
    3. Dairyo Y
    4. Yasunaga K
    5. Morikawa RK
    6. Emoto K

    (2013) Compartmentalized calcium transients trigger dendrite pruning in Drosophila sensory neurons

    Science 340:1475–1478.

    https://doi.org/10.1126/science.1234879

    • PubMed
    • Google Scholar
30. 1. Kaneko T
    2. Macara AM
    3. Li R
    4. Hu Y
    5. Iwasaki K
    6. Dunnings Z
    7. Firestone E
    8. Horvatic S
    9. Guntur A
    10. Shafer OT
    11. Yang CH
    12. Zhou J
    13. Ye B

    (2017) Serotonergic modulation enables Pathway-Specific plasticity in a developing sensory circuit in Drosophila

    Neuron 95:722.

    https://doi.org/10.1016/j.neuron.2017.07.023

    • PubMed
    • Google Scholar
31. 1. Kardash E
    2. Bandemer J
    3. Raz E

    (2011) Imaging protein activity in live embryos using fluorescence resonance energy transfer biosensors

    Nature Protocols 6:1835–1846.

    https://doi.org/10.1038/nprot.2011.395

    • PubMed
    • Google Scholar
32. 1. Kaur G
    2. Delluc-Clavieres A
    3. Poon IKH
    4. Forwood JK
    5. Glover DJ
    6. Jans DA

    (2010) Calmodulin-dependent nuclear import of HMG-box family nuclear factors: importance of the role of SRY in sex reversal

    Biochemical Journal 430:39–48.

    https://doi.org/10.1042/BJ20091758

    • Google Scholar
33. 1. Kim HJ
    2. Fan X
    3. Gabbi C
    4. Yakimchuk K
    5. Parini P
    6. Warner M
    7. Gustafsson JA

    (2008) Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia

    PNAS 105:2094–2099.

    https://doi.org/10.1073/pnas.0711599105

    • PubMed
    • Google Scholar
34. 1. Kim SH
    2. Zhan L
    3. Hanson KA
    4. Tibbetts RS

    (2012) High-content RNAi screening identifies the Type 1 inositol triphosphate receptor as a modifier of TDP-43 localization and neurotoxicity

    Human Molecular Genetics 21:4845–4856.

    https://doi.org/10.1093/hmg/dds321

    • Google Scholar
35. 1. Leroy F
    2. Lamotte d'Incamps B
    3. Imhoff-Manuel RD
    4. Zytnicki D

    (2014) Early intrinsic hyperexcitability does not contribute to motoneuron degeneration in amyotrophic lateral sclerosis

    eLife 3:e04046.

    https://doi.org/10.7554/eLife.04046

    • Google Scholar
36. 1. Li Y
    2. Ray P
    3. Rao EJ
    4. Shi C
    5. Guo W
    6. Chen X
    7. Woodruff EA
    8. Fushimi K
    9. Wu JY

    (2010) A Drosophila model for TDP-43 proteinopathy

    PNAS 107:3169–3174.

    https://doi.org/10.1073/pnas.0913602107

    • Google Scholar
37. 1. Lin MJ
    2. Cheng CW
    3. Shen CK

    (2011) Neuronal function and dysfunction of Drosophila dTDP

    PLOS ONE 6:e20371.

    https://doi.org/10.1371/journal.pone.0020371

    • PubMed
    • Google Scholar
38. 1. Ling SC
    2. Polymenidou M
    3. Cleveland DW

    (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis

    Neuron 79:416–438.

    https://doi.org/10.1016/j.neuron.2013.07.033

    • PubMed
    • Google Scholar
39. 1. Liu Z
    2. Cao J
    3. Gao X
    4. Ma Q
    5. Ren J
    6. Xue Y

    (2011) GPS-CCD: a novel computational program for the prediction of calpain cleavage sites

    PLOS ONE 6:e19001.

    https://doi.org/10.1371/journal.pone.0019001

    • PubMed
    • Google Scholar
40. 1. Lu Y
    2. Ferris J
    3. Gao FB

    (2009) Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching

    Molecular Brain 2:30.

    https://doi.org/10.1186/1756-6606-2-30

    • PubMed
    • Google Scholar
41. 1. Mason DA
    2. Mathe E
    3. Fleming RJ
    4. Goldfarb DS

    (2003)

    The Drosophila melanogaster importin alpha3 locus encodes an essential gene required for the development of both larval and adult tissues

    Genetics 165:1943–1958.

    • Google Scholar
42. 1. Matunis EL
    2. Matunis MJ
    3. Dreyfuss G

    (1992) Characterization of the major hnRNP proteins from Drosophila melanogaster

    Journal of Cell Biology 116:257–269.

    https://doi.org/10.1083/jcb.116.2.257

    • Google Scholar
43. 1. McDonald KK
    2. Aulas A
    3. Destroismaisons L
    4. Pickles S
    5. Beleac E
    6. Camu W
    7. Rouleau GA
    8. Vande Velde C

    (2011) TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1

    Human Molecular Genetics 20:1400–1410.

    https://doi.org/10.1093/hmg/ddr021

    • PubMed
    • Google Scholar
44. 1. Miguel L
    2. Frébourg T
    3. Campion D
    4. Lecourtois M

    (2011) Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies

    Neurobiology of Disease 41:398–406.

    https://doi.org/10.1016/j.nbd.2010.10.007

    • PubMed
    • Google Scholar
45. 1. Moroianu J
    2. Hijikata M
    3. Blobel G
    4. Radu A

    (1995) Mammalian karyopherin alpha 1 beta and alpha 2 beta heterodimers: alpha 1 or alpha 2 subunit binds nuclear localization signal and beta subunit interacts with peptide repeat-containing nucleoporins

    PNAS 92:6532–6536.

    https://doi.org/10.1073/pnas.92.14.6532

    • PubMed
    • Google Scholar
46. 1. Mouzat K
    2. Molinari N
    3. Kantar J
    4. Polge A
    5. Corcia P
    6. Couratier P
    7. Clavelou P
    8. Juntas-Morales R
    9. Pageot N
    10. Lobaccaro J-A
    11. Raoul C
    12. Lumbroso S
    13. Camu W

    (2018) Liver X receptor genes variants modulate ALS phenotype

    Molecular Neurobiology 55:1959–1965.

    https://doi.org/10.1007/s12035-017-0453-2

    • PubMed
    • Google Scholar
47. 1. Nakashima-Yasuda H
    2. Uryu K
    3. Robinson J
    4. Xie SX
    5. Hurtig H
    6. Duda JE
    7. Arnold SE
    8. Siderowf A
    9. Grossman M
    10. Leverenz JB
    11. Woltjer R
    12. Lopez OL
    13. Hamilton R
    14. Tsuang DW
    15. Galasko D
    16. Masliah E
    17. Kaye J
    18. Clark CM
    19. Montine TJ
    20. Lee VM
    21. Trojanowski JQ

    (2007) Co-morbidity of TDP-43 proteinopathy in lewy body related diseases

    Acta Neuropathologica 114:221–229.

    https://doi.org/10.1007/s00401-007-0261-2

    • PubMed
    • Google Scholar
48. 1. Natalizio AH
    2. Matera AG

    (2013) Identification and characterization of Drosophila Snurportin reveals a role for the import receptor Moleskin/importin-7 in snRNP biogenesis

    Molecular Biology of the Cell 24:2932–2942.

    https://doi.org/10.1091/mbc.e13-03-0118

    • Google Scholar
49. 1. Neumann M
    2. Sampathu DM
    3. Kwong LK
    4. Truax AC
    5. Micsenyi MC
    6. Chou TT
    7. Bruce J
    8. Schuck T
    9. Grossman M
    10. Clark CM
    11. McCluskey LF
    12. Miller BL
    13. Masliah E
    14. Mackenzie IR
    15. Feldman H
    16. Feiden W
    17. Kretzschmar HA
    18. Trojanowski JQ
    19. Lee VM

    (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

    Science 314:130–133.

    https://doi.org/10.1126/science.1134108

    • PubMed
    • Google Scholar
50. 1. Nguyen DKH
    2. Thombre R
    3. Wang J

    (2019) Autophagy as a common pathway in amyotrophic lateral sclerosis

    Neuroscience Letters 697:34–48.

    https://doi.org/10.1016/j.neulet.2018.04.006

    • PubMed
    • Google Scholar
51. 1. Nishimura AL
    2. Zupunski V
    3. Troakes C
    4. Kathe C
    5. Fratta P
    6. Howell M
    7. Gallo JM
    8. Hortobágyi T
    9. Shaw CE
    10. Rogelj B

    (2010) Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration

    Brain 133:1763–1771.

    https://doi.org/10.1093/brain/awq111

    • PubMed
    • Google Scholar
52. 1. Nitabach MN
    2. Wu Y
    3. Sheeba V
    4. Lemon WC
    5. Strumbos J
    6. Zelensky PK
    7. White BH
    8. Holmes TC

    (2006) Electrical hyperexcitation of lateral ventral pacemaker neurons desynchronizes downstream circadian oscillators in the fly circadian circuit and induces multiple behavioral periods

    Journal of Neuroscience 26:479–489.

    https://doi.org/10.1523/JNEUROSCI.3915-05.2006

    • PubMed
    • Google Scholar
53. 1. Noldus LPJJ
    2. Spink AJ
    3. Tegelenbosch RAJ

    (2001) EthoVision: a versatile video tracking system for automation of behavioral experiments

    Behavior Research Methods, Instruments, & Computers 33:398–414.

    https://doi.org/10.3758/BF03195394

    • Google Scholar
54. 1. Nonaka T
    2. Arai T
    3. Buratti E
    4. Baralle FE
    5. Akiyama H
    6. Hasegawa M

    (2009) Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells

    FEBS Letters 583:394–400.

    https://doi.org/10.1016/j.febslet.2008.12.031

    • PubMed
    • Google Scholar
55. 1. Park JH
    2. Chung CG
    3. Seo J
    4. Lee BH
    5. Lee YS
    6. Kweon JH
    7. Lee SB

    (2020) C9orf72 -Associated Arginine-Rich dipeptide repeat proteins reduce the number of golgi outposts and dendritic branches in Drosophila Neurons

    Molecules and Cells 43:821–830.

    https://doi.org/10.14348/molcells.2020.0130

    • PubMed
    • Google Scholar
56. 1. Pinarbasi ES
    2. Cağatay T
    3. Fung HYJ
    4. Li YC
    5. Chook YM
    6. Thomas PJ

    (2018) Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization

    Scientific Reports 8:7083.

    https://doi.org/10.1038/s41598-018-25008-4

    • PubMed
    • Google Scholar
57. 1. Renton AE
    2. Majounie E
    3. Waite A
    4. Simón-Sánchez J
    5. Rollinson S
    6. Gibbs JR
    7. Schymick JC
    8. Laaksovirta H
    9. van Swieten JC
    10. Myllykangas L
    11. Kalimo H
    12. Paetau A
    13. Abramzon Y
    14. Remes AM
    15. Kaganovich A
    16. Scholz SW
    17. Duckworth J
    18. Ding J
    19. Harmer DW
    20. Hernandez DG
    21. Johnson JO
    22. Mok K
    23. Ryten M
    24. Trabzuni D
    25. Guerreiro RJ
    26. Orrell RW
    27. Neal J
    28. Murray A
    29. Pearson J
    30. Jansen IE
    31. Sondervan D
    32. Seelaar H
    33. Blake D
    34. Young K
    35. Halliwell N
    36. Callister JB
    37. Toulson G
    38. Richardson A
    39. Gerhard A
    40. Snowden J
    41. Mann D
    42. Neary D
    43. Nalls MA
    44. Peuralinna T
    45. Jansson L
    46. Isoviita VM
    47. Kaivorinne AL
    48. Hölttä-Vuori M
    49. Ikonen E
    50. Sulkava R
    51. Benatar M
    52. Wuu J
    53. Chiò A
    54. Restagno G
    55. Borghero G
    56. Sabatelli M
    57. Heckerman D
    58. Rogaeva E
    59. Zinman L
    60. Rothstein JD
    61. Sendtner M
    62. Drepper C
    63. Eichler EE
    64. Alkan C
    65. Abdullaev Z
    66. Pack SD
    67. Dutra A
    68. Pak E
    69. Hardy J
    70. Singleton A
    71. Williams NM
    72. Heutink P
    73. Pickering-Brown S
    74. Morris HR
    75. Tienari PJ
    76. Traynor BJ
    77. ITALSGEN Consortium

    (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

    Neuron 72:257–268.

    https://doi.org/10.1016/j.neuron.2011.09.010

    • PubMed
    • Google Scholar
58. 1. Rumpf S
    2. Bagley JA
    3. Thompson-Peer KL
    4. Zhu S
    5. Gorczyca D
    6. Beckstead RB
    7. Jan LY
    8. Jan YN

    (2014) Drosophila Valosin-Containing protein is required for dendrite pruning through a regulatory role in mRNA metabolism

    PNAS 111:7331–7336.

    https://doi.org/10.1073/pnas.1406898111

    • PubMed
    • Google Scholar
59. 1. Saxena S
    2. Roselli F
    3. Singh K
    4. Leptien K
    5. Julien JP
    6. Gros-Louis F
    7. Caroni P

    (2013) Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival

    Neuron 80:80–96.

    https://doi.org/10.1016/j.neuron.2013.07.027

    • PubMed
    • Google Scholar
60. 1. Schwab C
    2. Arai T
    3. Hasegawa M
    4. Yu S
    5. McGeer PL

    (2008) Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease

    Journal of Neuropathology & Experimental Neurology 67:1159–1165.

    https://doi.org/10.1097/NEN.0b013e31818e8951

    • PubMed
    • Google Scholar
61. 1. Schwenk BM
    2. Hartmann H
    3. Serdaroglu A
    4. Schludi MH
    5. Hornburg D
    6. Meissner F
    7. Orozco D
    8. Colombo A
    9. Tahirovic S
    10. Michaelsen M
    11. Schreiber F
    12. Haupt S
    13. Peitz M
    14. Brüstle O
    15. Küpper C
    16. Klopstock T
    17. Otto M
    18. Ludolph AC
    19. Arzberger T
    20. Kuhn PH
    21. Edbauer D

    (2016) TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons

    The EMBO Journal 35:2350–2370.

    https://doi.org/10.15252/embj.201694221

    • PubMed
    • Google Scholar
62. 1. Shahheydari H
    2. Ragagnin A
    3. Walker AK
    4. Toth RP
    5. Vidal M
    6. Jagaraj CJ
    7. Perri ER
    8. Konopka A
    9. Sultana JM
    10. Atkin JD

    (2017) Protein quality control and the amyotrophic lateral sclerosis/Frontotemporal dementia continuum

    Frontiers in Molecular Neuroscience 10:119.

    https://doi.org/10.3389/fnmol.2017.00119

    • PubMed
    • Google Scholar
63. 1. Solomon DA
    2. Stepto A
    3. Au WH
    4. Adachi Y
    5. Diaper DC
    6. Hall R
    7. Rekhi A
    8. Boudi A
    9. Tziortzouda P
    10. Lee YB
    11. Smith B
    12. Bridi JC
    13. Spinelli G
    14. Dearlove J
    15. Humphrey DM
    16. Gallo JM
    17. Troakes C
    18. Fanto M
    19. Soller M
    20. Rogelj B
    21. Parsons RB
    22. Shaw CE
    23. Hortobágyi T
    24. Hirth F

    (2018) A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegeneration

    Brain 141:2908–2924.

    https://doi.org/10.1093/brain/awy241

    • PubMed
    • Google Scholar
64. 1. Sowa AS
    2. Martin E
    3. Martins IM
    4. Schmidt J
    5. Depping R
    6. Weber JJ
    7. Rother F
    8. Hartmann E
    9. Bader M
    10. Riess O
    11. Tricoire H
    12. Schmidt T

    (2018) Karyopherin α-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3

    PNAS 115:E2624–E2633.

    https://doi.org/10.1073/pnas.1716071115

    • Google Scholar
65. 1. Taylor JP
    2. Brown RH
    3. Cleveland DW

    (2016) Decoding ALS: from genes to mechanism

    Nature 539:197–206.

    https://doi.org/10.1038/nature20413

    • Google Scholar
66. 1. Termsarasab P
    2. Thammongkolchai T
    3. Gao J
    4. Wang L
    5. Liang J
    6. Wang X

    (2020) Cytoplasmic mislocalization and mitochondrial colocalization of TDP-43 are common features between normal aged and young mice

    Experimental Biology and Medicine 245:1584–1593.

    https://doi.org/10.1177/1535370220914253

    • Google Scholar
67. 1. Thurmond J
    2. Goodman JL
    3. Strelets VB
    4. Attrill H
    5. Gramates LS
    6. Marygold SJ
    7. Matthews BB
    8. Millburn G
    9. Antonazzo G
    10. Trovisco V
    11. Kaufman TC
    12. Calvi BR
    13. FlyBase Consortium

    (2019) FlyBase 2.0: the next generation

    Nucleic Acids Research 47:D759–D765.

    https://doi.org/10.1093/nar/gky1003

    • PubMed
    • Google Scholar
68. 1. Topham MK
    2. Bunting M
    3. Zimmerman GA
    4. McIntyre TM
    5. Blackshear PJ
    6. Prescott SM

    (1998) Protein kinase C regulates the nuclear localization of diacylglycerol kinase-ζ

    Nature 394:697–700.

    https://doi.org/10.1038/29337

    • Google Scholar
69. 1. Uchino A
    2. Takao M
    3. Hatsuta H
    4. Sumikura H
    5. Nakano Y
    6. Nogami A
    7. Saito Y
    8. Arai T
    9. Nishiyama K
    10. Murayama S

    (2015) Incidence and extent of TDP-43 accumulation in aging human brain

    Acta Neuropathologica Communications 3:35.

    https://doi.org/10.1186/s40478-015-0215-1

    • PubMed
    • Google Scholar
70. 1. Valovka T
    2. Verdier F
    3. Cramer R
    4. Zhyvoloup A
    5. Fenton T
    6. Rebholz H
    7. Wang M-L
    8. Gzhegotsky M
    9. Lutsyk A
    10. Matsuka G
    11. Filonenko V
    12. Wang L
    13. Proud CG
    14. Parker PJ
    15. Gout IT

    (2003) Protein Kinase C Phosphorylates Ribosomal Protein S6 Kinase βII and Regulates Its Subcellular Localization

    Molecular and Cellular Biology 23:852–863.

    https://doi.org/10.1128/MCB.23.3.852-863.2003

    • Google Scholar
71. 1. Vanden Broeck L
    2. Naval-Sánchez M
    3. Adachi Y
    4. Diaper D
    5. Dourlen P
    6. Chapuis J
    7. Kleinberger G
    8. Gistelinck M
    9. Van Broeckhoven C
    10. Lambert JC
    11. Hirth F
    12. Aerts S
    13. Callaerts P
    14. Dermaut B

    (2013) TDP-43 loss-of-function causes neuronal loss due to defective steroid receptor-mediated gene program switching in Drosophila

    Cell Reports 3:160–172.

    https://doi.org/10.1016/j.celrep.2012.12.014

    • PubMed
    • Google Scholar
72. 1. Vogler TO
    2. Wheeler JR
    3. Nguyen ED
    4. Hughes MP
    5. Britson KA
    6. Lester E
    7. Rao B
    8. Betta ND
    9. Whitney ON
    10. Ewachiw TE
    11. Gomes E
    12. Shorter J
    13. Lloyd TE
    14. Eisenberg DS
    15. Taylor JP
    16. Johnson AM
    17. Olwin BB
    18. Parker R

    (2018) TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle

    Nature 563:508–513.

    https://doi.org/10.1038/s41586-018-0665-2

    • Google Scholar
73. 1. Voigt A
    2. Herholz D
    3. Fiesel FC
    4. Kaur K
    5. Müller D
    6. Karsten P
    7. Weber SS
    8. Kahle PJ
    9. Marquardt T
    10. Schulz JB

    (2010) TDP-43-mediated neuron loss in vivo requires RNA-binding activity

    PLOS ONE 5:e12247.

    https://doi.org/10.1371/journal.pone.0012247

    • PubMed
    • Google Scholar
74. 1. von Lewinski F
    2. Keller BU

    (2005) Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS

    Trends in Neurosciences 28:494–500.

    https://doi.org/10.1016/j.tins.2005.07.001

    • PubMed
    • Google Scholar
75. 1. Vosler PS
    2. Brennan CS
    3. Chen J

    (2008) Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration

    Molecular Neurobiology 38:78–100.

    https://doi.org/10.1007/s12035-008-8036-x

    • PubMed
    • Google Scholar
76. 1. Wang J-W
    2. Brent JR
    3. Tomlinson A
    4. Shneider NA
    5. McCabe BD

    (2011) The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span

    Journal of Clinical Investigation 121:4118–4126.

    https://doi.org/10.1172/JCI57883

    • Google Scholar
77. 1. Wils H
    2. Kleinberger G
    3. Janssens J
    4. Pereson S
    5. Joris G
    6. Cuijt I
    7. Smits V
    8. Ceuterick-de Groote C
    9. Van Broeckhoven C
    10. Kumar-Singh S

    (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration

    PNAS 107:3858–3863.

    https://doi.org/10.1073/pnas.0912417107

    • PubMed
    • Google Scholar
78. 1. Winton MJ
    2. Igaz LM
    3. Wong MM
    4. Kwong LK
    5. Trojanowski JQ
    6. Lee VM-Y

    (2008) Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) Induces Disease-like redistribution, sequestration, and aggregate formation

    Journal of Biological Chemistry 283:13302–13309.

    https://doi.org/10.1074/jbc.M800342200

    • Google Scholar
79. 1. Yadav S
    2. Younger SH
    3. Zhang L
    4. Thompson-Peer KL
    5. Li T
    6. Jan LY
    7. Jan YN

    (2019) Glial ensheathment of the somatodendritic compartment regulates sensory neuron structure and activity

    PNAS 116:5126–5134.

    https://doi.org/10.1073/pnas.1814456116

    • PubMed
    • Google Scholar
80. 1. Yamashita T
    2. Hideyama T
    3. Hachiga K
    4. Teramoto S
    5. Takano J
    6. Iwata N
    7. Saido TC
    8. Kwak S

    (2012) A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology

    Nature Communications 3:1307.

    https://doi.org/10.1038/ncomms2303

    • PubMed
    • Google Scholar
81. 1. Yang Z
    2. Lin F
    3. Robertson CS
    4. Wang KK

    (2014) Dual vulnerability of TDP-43 to calpain and caspase-3 proteolysis after neurotoxic conditions and traumatic brain injury

    Journal of Cerebral Blood Flow & Metabolism 34:1444–1452.

    https://doi.org/10.1038/jcbfm.2014.105

    • PubMed
    • Google Scholar

Author details

1. Jeong Hyang Park

   1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
   2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea

   Contribution

   Conceptualization, Resources, Formal analysis, Investigation, Visualization, Writing - original draft, Writing - review and editing

   Contributed equally with

   Chang Geon Chung

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-7392-8366

2. Chang Geon Chung

   1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
   2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea

   Contribution

   Conceptualization, Resources, Formal analysis, Investigation, Visualization, Writing - original draft, Writing - review and editing

   Contributed equally with

   Jeong Hyang Park

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0001-8155-4926

3. Sung Soon Park

   1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
   2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea

   Contribution

   Formal analysis, Investigation, Visualization, Writing - original draft

   Competing interests

   No competing interests declared

4. Davin Lee

   1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
   2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea

   Contribution

   Formal analysis, Investigation, Visualization, Writing - original draft

   Competing interests

   No competing interests declared

5. Kyung Min Kim

   1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
   2. School of Biological Sciences, Seoul National University, Seoul, Republic of Korea

   Contribution

   Formal analysis, Investigation, Visualization

   Competing interests

   No competing interests declared

6. Yeonjin Jeong

   1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
   2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea

   Contribution

   Formal analysis, Visualization

   Competing interests

   No competing interests declared

7. Eun Seon Kim

   1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
   2. Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea

   Contribution

   Investigation

   Competing interests

   No competing interests declared

8. Jae Ho Cho

   1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
   2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea

   Contribution

   Formal analysis

   Competing interests

   No competing interests declared

9. Yu-Mi Jeon

   Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea

   Contribution

   Investigation

   Competing interests

   No competing interests declared

10. C-K James Shen

    Taipei Medical University/Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan

    Contribution

    Resources

    Competing interests

    No competing interests declared

11. Hyung-Jun Kim

    Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea

    Contribution

    Investigation

    Competing interests

    No competing interests declared

12. Daehee Hwang

    School of Biological Sciences, Seoul National University, Seoul, Republic of Korea

    Contribution

    Conceptualization, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing

    Competing interests

    No competing interests declared

13. Sung Bae Lee

    1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
    2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
    3. Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea

    Contribution

    Conceptualization, Resources, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing

    For correspondence

    sblee@dgist.ac.kr

    Competing interests

    No competing interests declared

    "This ORCID iD identifies the author of this article:" 0000-0002-8980-6769

• 3,308

  views

• 533

  downloads

• 21

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.